TY  - RPRT
TI  - Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.
AU  - Barani Karikalan
AU  - Ye Htut Linn
AU  - Shiueh Lian Mok
PY  - 2026
DO  - 10.1016/j.bulcan.2026.04.016
UR  - https://pubmed.ncbi.nlm.nih.gov/42711224/
ID  - 42711224
ER  -